Pediatric Praziquantel Consortium
@PedPZQ
Our mission is to provide access to a suitable pediatric treatment option for preschool-aged children with schistosomiasis.
In this article, @GHITFund reflects on the journey of "one of the Fund's key successes" – developing a new treatment for #schistosomiasis in preschool-aged children. Thanks to GHIT and all our partners for their continued support. ghitfund.org/newsroom/news/…
📢@EMA_News has adopted a positive opinion of our new pediatric treatment option for preschool-aged children with #schistosomiasis. This is the result of more than a decade of intense collaboration. We couldn't be more proud! pediatricpraziquantelconsortium.org/newsroom/europ… @EDCTP @GHITFund
Our ADOPT program is developing an implementation approach tailored to local conditions in endemic countries for introducing our potential new pediatric treatment for #schistosomiasis, once approved. Find out more about where we currently stand 👉 bit.ly/3DFPDec
Big news! 🎉 The first preschool-aged child has been treated with our new pediatric treatment for #schistosomiasis in Uganda. 🌍 A major step in addressing the treatment gap for young children fighting this #NeglectedTropicalDisease! 💊👶 pediatricpraziquantelconsortium.org/newsroom/first…
🔵Video Series🔵 Innovative Approaches to Combat Schistosomiasis📹 We interviewed Dr. Clarer Jones Mwansasu, #NTD Program Manager, Ministry of Health, United Republic of #Tanzania, about Combating #Schistosomiasis in Tanzania. @ADP_health @UNDP youtu.be/aZzpQg9GbSA
Last week, @PedPZQ members, including country reps from Kenya, Uganda, and Cote d'Ivoire, were in Tokyo for a strategy meeting on the challenges & opportunities for the access and delivery of our new pediatric treatment option for #schistosomiasis. @GHITFund @merckgroup @EDCTP
Yesterday in Tokyo, a strategic dialogue by #UnitingEfforts – an initiative by GHIT, @UNDP -led @ADP_health and Japan- is bringing together key stakeholders, incl @PedPZQ partners, to prepare for equitable introduction of the new treatment option for paediatric #schistosomiasis.
📢We have exciting news: our new pediatric treatment option for preschool-aged children with #schistosomiasis is now @WHO-prequalified! pediatricpraziquantelconsortium.org/newsroom/who-i… #BeatNTDs #OneStepCloser @EDCTP @GHITFund
Thank you Uniting Efforts for Innovation, Access and Delivery – a joint initiative of the @UNDP-led @ADP_health, the @GHITFund and the Government of Japan for organizing this important and fruitful meeting. Meeting report now available 👇 #Schistosomiasi #PublicPrivatePartners
With a new treatment option against #schistosomiasis for preschool-aged children on the horizon, key stakeholders recently convened to discuss challenges lying ahead and collaborative efforts needed to ensure country readiness for equitable access. More: adphealth.org/post/116/ensur…
Today is #WorldNTDDay. Since 2014, EDCTP has invested €80M to help #BeatNTDs. Several of our #research funding have achieved important milestones that can help control and eliminate these diseases. Read our full message 👉tinyurl.com/mr2tf7f8
Today is #WorldNTDDay. As an international #PublicPrivatePartnership fighting to eliminate #Schistosomiasis, one of 21 NTDs classified by the WHO, we are proud to show our support 👉 pediatricpraziquantelconsortium.org/newsroom/world… #UniteActEliminate #BeatNTDs #GlobalHealth @EDCTP @GHITFund
🗓️Register now for this hybrid session on sustainable access for #NTD health technologies during #CPHIA2023 on Monday 27 November. Our @PedPZQ will be represented by Beatrice Greco @merckgroup. undp.zoom.us/webinar/regist…
Our Consortium member, Peter Steinmann, representing @PedPZQ at this year's #ECTMIH2023. @EDCTP @GHITFund @WHO @DNDi #Schistosomiasis #BeatNTDs
Peter Steinmann in a panel discussion on closing the gap for children affected by #NTDs with @DNDi & @WHO “We have no praziquantel formulations for preschool children as all efforts have been on those of school age who are reached with drugs through the school system." @PedPZQ
During a workshop on #NTDs at this year's #WHS2023, @EDCTP Executive Director Dr Michael Makanga gave a presentation in which he provided ONE example of successful product development: our @PedPZQ! 📷 by Dr Jutta Reinhard-Rupp, Chair of the Consortium Board from @merckgroup
In case you missed it, take a look at the latest edition of our #Newsletter, released last week 👉 mailchi.mp/a3c3d7b33291/p…
#DAC2023 reminds of hundreds of millions #AfricanChildren who remain vulnerable to #Schistosomiasis. Despite efforts by @WHO & #NTDPartners providing enhanced access to #praziquantel, #EducationForEmpowerment is needed to keep the #AfricanChild away from infection & to #BeatNTDs
Read up on EDCTP's progress and achievements in: EDCTP annual report 2022 - Connecting numbers to impact 📥Download the PDF tinyurl.com/2yx6fh9c 🖥️ Read the digital report tinyurl.com/293szpke
We are proud to join 20+ organizations and individuals to call for the acceleration of R&D, access, and delivery for neglected tropical diseases, and adopt the #NagasakiOutcomesStatement Read more about the Outcomes Statement here. ghitfund.org/newsroom/press…